New Trial For TPOXX Monkeypox Drug Launched in Africa


The testing of TPOXX is being launched in central Africa as a potential treatment for monkeypox. Currently, the antiviral drug TPOXX is only approved for smallpox treatment by the FDA but could be used to treat monkeypox as the drug targets a protein found in both monkeypox and smallpox. 

To read more about the TPOXX drug by Dennis Thompson on US News, click here

Comments are closed.

Skip to toolbar